Symbol | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
BIIB | 19 B | 8.0 | 2.5 | 18.82 | 34 | 32 | 7.3 | 8.3 | 18 | 1 | 2 |
NVO | 216 B | 11 | 0.74 | 9.36 | 49 | 51 | 19 | 15 | 21 | 1 | 3 |
BMY | 93 B | 6.5 | 1.2 | 6.68 | 33 | 40 | 0.60 | -22 | 24 | 1 | 1 |
GRFS | 9.1 B | 9.5 | 2.6 | 0.86 | 18 | 23 | 4.0 | 750 | 20 | 2 | 2 |
NVS | 229 B | 13 | 0.82 | 3.48 | 36 | 42 | 15 | 29 | 22 | 2 | 3 |
AZN | 231 B | 13 | 0.86 | 4.59 | 24 | 33 | 11 | 27 | 23 | 2 | 1 |
OGN | 2.2 B | 2.0 | 1.7 | 2.10 | 22 | 27 | -6.7 | -57 | 25 | 2 | 2 |
PFE | 141 B | 8.4 | 1.3 | 3.05 | 35 | 37 | -7.8 | -5.3 | 25 | 2 | 1 |
GSK | 75 B | 8.7 | 0.87 | 0.89 | 30 | 28 | 1.3 | 23 | 25 | 2 | 0 |
SNY | 117 B | 9.7 | 1.3 | 12.62 | 18 | 26 | -5.7 | 266 | 25 | 2 | 1 |
MRK | 203 B | 8.6 | 3.67 | 36 | 45 | -1.9 | -17 | 27 | 2 | 3 | |
LLY | 688 B | 33 | 1.4 | 3.59 | 42 | 44 | 45 | 23 | 20 | 3 | 2 |
JNJ | 411 B | 16 | 1.00 | 7.84 | 28 | 33 | 5.8 | 18 | 25 | 3 | 0 |
ABBV | 351 B | 16 | 2.93 | 37 | 47 | 6.6 | -32 | 27 | 3 | 2 | |
AMGN | 161 B | 14 | 1.2 | 16.38 | 28 | 46 | 9.4 | 31 | 5 | 1 | |
GILD | 140 B | 15 | 1.4 | 7.00 | 38 | 47 | -0.30 | 32 | 6 | 2 | |
MIRA | 28 M | -3.1 | 12 | 0.07 | 0.00 | 0.00 | 49 | 22 | 1 | ||
AMRN | 313 M | -72 | 3.3 | 0.72 | 9.3 | -22 | 7.8 | 54 | 24 | 1 | |
SCLX | 79 M | -35 | 0.10 | 1.06 | -557 | -178 | -54 | 80 | 58 | 0 | |
Q1 = 8.6 | Q3 = 1.7 | Q3 = 36 | Q3 = 45 | Q3 = 11 | Q3 = 29 |
Total Records: 19. | Quotes | Help |
© George Elgin | Questions or Comments | Data last Modified 08/06/25 |